Schonfeld Strategic Advisors LLC Poseida Therapeutics, Inc. Transaction History

Schonfeld Strategic Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$6.23 - $7.6 $1.8 Million - $2.2 Million	-289,179 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	$7.09 - $10.71 $245,143 - $370,308	34,576 Added 13.58%	289,179 $2.11 Million
Q2 2021 Aug 16, 2021	SELL	$7.96 - $10.07 $1.28 Million - $1.62 Million	-161,089 Reduced 38.75%	254,603 $2.55 Million
Q1 2021 May 17, 2021	BUY	$8.51 - $11.91 $3.54 Million - $4.95 Million	415,692 New	415,692 $3.97 Million
Q4 2020 Feb 16, 2021	SELL	$8.29 - $11.7 $405,961 - $572,949	-48,970 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$8.09 - $16.25 $396,167 - $795,762	48,970 New	48,970 $0

38.5M

377K

22.2K

Ticker PSTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 85,775,600
Market Cap $810M
Description
Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.